Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Improving type 1 diabetes screening awareness among women is critical. Here’s why.

Shara Bialo, MD
Conditions
January 31, 2025
Share
Tweet
Share

As a board-certified pediatric endocrinologist, the field medical director for type 1 diabetes immunology (T1D) at Sanofi, and someone who was diagnosed with T1D as a child, it’s fair to say that much of my life has revolved around the disease.

I could recite the risk factors for T1D in my sleep; I’ve seen first-hand the perils of an unexpected T1D diagnosis—including diabetic ketoacidosis (DKA); I’m keenly aware that those with a family history of T1D are up to 15 times more likely to develop the disease themselves; and I know just how important T1D autoantibody screening can be in helping to identify a person’s risk of developing the disease, even before symptoms occur.

And yet, it may surprise you to learn that for years, I struggled with getting my own children screened for T1D. As a doctor, I knew it was important. But as a mom—as their mom—I avoided it, filled with tremendous guilt and shame at the prospect of passing my disease along to them (unfounded as that obviously is).

Eventually, I did screen my children for T1D and am so thankful I made that decision when I did. But this experience brought to light a very unsettling reality: living with T1D can have an emotional impact, and if I—a medical professional and someone who is acutely aware of the benefits of T1D screening—struggled with the decision to do so, how might others feel?

This realization becomes even more complex when you consider that many people aren’t aware that T1D screening even exists—particularly women. In fact, according to a subgroup analysis of a survey conducted by Beyond Type 1 and commissioned by Sanofi, while nearly half of women with T1D (48 percent) considered themselves proactive about their health, only one in five screened prior to their diagnosis. What’s more, the findings showed men were both more likely to know that T1D screening exists and more likely to have become aware of their diagnosis before their symptoms started.

Why does this matter? Because not knowing you’re at risk of developing a serious disease like T1D can have impacts. In fact, according to the survey, women with T1D were more likely than men with T1D to say their lives would have been different (86 percent vs. 84 percent) if they’d learned sooner about their diagnosis, and 97 percent of women with T1D said their overall health would have improved had they known sooner about their risk of developing the disease.

This is why, as a health care community, we must do more to recognize this unseen burden and improve our efforts to educate the public—and women, in particular—about the value and importance of T1D screening. We can’t let lack of information or awareness be barriers. We must lead from the front and be more proactive in discussing T1D screening with individuals at risk who walk through our doors.

As HCPs, this is our vocation: to empower people with the tools they need to take charge of their own health. We have a responsibility to create an environment where individuals, regardless of age, gender, or background, feel comfortable expressing their concerns and understand their options. We must keep lines of communication open during annual doctor’s visits to ensure that we’re 1) listening for and addressing potential risk factors for type 1 diabetes and 2) advocating for the importance of early screening. And in this pursuit, there’s always more work to be done. Each and every day, we must come to work thinking creatively and innovatively about how to bridge longstanding divides impeding knowledge-sharing and, perhaps most critically, driving necessary and timely action.

Of course, as I write this, I also recognize that education is not a one-size-fits-all effort, so it’s critical we tailor our education to reflect women’s multifaceted experiences—as mothers, daughters, aunts, and sisters. We must advocate for them and ensure they have the knowledge and resources that allow them to prioritize their health and the health of those they love and care for. Thankfully, by using education to help bridge longstanding awareness divides, I’m confident that we as HCPs can create a future where people can reduce their likelihood of experiencing the unexpected impacts of a T1D diagnosis.

Background and methodology

The Cost of Not Knowing survey, from Beyond Type 1, was commissioned by Sanofi and conducted by Wakefield Research. The Cost of Not Knowing was conducted via two survey instruments—one among 1,000 US adults with type 1 diabetes and a second among 1,000 US caregivers to children under the age of 18 with type 1 diabetes, between March 15 and March 29, 2024, using an email invitation and an online survey. The findings in this document reflect the subgroups of women (n=499) and men (n=500) living with type 1 diabetes.

Results of any sample are subject to sampling variation. The magnitude of the variation is measurable and is affected by the number of interviews and the level of the percentages expressing the results. For the interviews conducted in this particular study, the chances are 95 in 100 that a survey result does not vary, plus or minus, by more than 3.1 percentage points from the result that would be obtained if interviews had been conducted with all persons in the universe represented by the sample.

Beyond Type 1 and Sanofi do not provide medical advice, diagnosis, or treatment—information is provided for educational purposes only. Your doctor is the best source of health information. Talk to your doctor if you have any questions about your health or treatment. The survey was conducted anonymously. Respondents were not made aware of the survey sponsor, and no personally identifiable information (PII) about the respondents was shared with the survey sponsor. Respondents were incentivized for their participation, in keeping with best practice for opinion research.

Shara Bialo is a pediatric endocrinologist.

ADVERTISEMENT

Prev

Chadwick Boseman's cancer battle reveals urgent need for personalized screenings [PODCAST]

January 30, 2025 Kevin 0
…
Next

Antipsychotic use has been rising in long-term care homes, but we can do something about it

January 31, 2025 Kevin 0
…

Tagged as: Diabetes, Endocrinology

Post navigation

< Previous Post
Chadwick Boseman's cancer battle reveals urgent need for personalized screenings [PODCAST]
Next Post >
Antipsychotic use has been rising in long-term care homes, but we can do something about it

ADVERTISEMENT

Related Posts

  • Type 1 diabetes is no fun

    Ryan Ritchie
  • Celebrating silver: 3 best practices for meeting people where they are with diabetes adherence

    Gary Marc Rothenberg, DPM
  • Why building your social media following is critical to your practice’s success

    Sheila Nazarian, MD
  • Don’t blame Big Pharma for insulin’s problems

    Rushi Nagalla
  • Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management

    Dinesh Arab, MD
  • How weight loss drugs are creating a medical dilemma

    Yasmine Kamgarhaghighi

More in Conditions

  • Why Hollywood’s allergy jokes are dangerous

    Lianne Mandelbaum, PT
  • Coconut oil’s role in Alzheimer’s and depression

    Marc Arginteanu, MD
  • Ancient health secrets for modern life

    Larry Kaskel, MD
  • How the internet broke the doctor-parent trust

    Wendy L. Hunter, MD
  • Mpox isn’t over: A silent epidemic is growing

    Melvin Sanicas, MD
  • How your family system secretly shapes your health

    Su Yeong Kim, PhD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
    • The crushing bureaucracy that’s driving independent physicians to extinction

      Scott Tzorfas, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • How I learned to love my unique name as a doctor

      Zoran Naumovski, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician
    • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

      Adwait Chafale | Meds

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
    • The crushing bureaucracy that’s driving independent physicians to extinction

      Scott Tzorfas, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • How I learned to love my unique name as a doctor

      Zoran Naumovski, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician
    • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

      Adwait Chafale | Meds

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...